The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

A rare disease in the US is one in 1,500, or fewer than 200,000 people, and an ultra-rare disease is one in 50,000 or fewer ...

Furthermore, postoperative problems such as nausea, muscle spasm, constipation, and skin breakdown due to immobility ... of pharmacological agents such as morphine (continuous infusion, patient ...

Zhanette Coffee, Ph.D., MSN, APRN, spent years working as an advanced practice nurse with certifications in family practice ...

Opioid testing information was unavailable in half of injury death investigations in the U.S. and in 1 in 10 unintentional ...

A new study from University of Toronto Engineering researchers points to practical strategies to prevent deaths from opioid ...

Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-opioid pain prospect. The biotech focused on low-dose results from its latest phase 2 trial, rather than the overall ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation. Purdue Pharma and the Sackler families agreed ...

The one-year, $100,000 grant will fund her research “Targeting G Protein Pathways In The Periaqueductal Gray To Optimize The Actions Of Opioids.” Morphine, oxycodone and other opioids possess ...